Karyopharm Therapeutics Inc.

SEC 4 · Filed

0001291963-26-000004Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date May 21, 2026

Grant, award or other acquisition by Greene Barry E

Security
Common Stock
Code
A
Shares
15,508
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-05-21",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on May 21, 2027; however, delivery of the shares is deferred until the earlier of (a) the date of the director\u0027s separation from service to Karyopharm Therapeutics Inc. and (b) a change-in-control event.",
    "F2": "Amounts reported in this Form 4 reflect the one-for fifteen reverse stock split effected by Karyopharm Therapeutics Inc. on February 25, 2025."
  },
  "owners": [
    {
      "cik": "0001291963",
      "name": "Greene Barry E",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "16415",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "15508",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}